Flex Pharma (FLKS) Tops Q4 EPS by 5c

Flex Pharma (NASDAQ: FLKS) reported Q4 EPS of ($0.51), $0.05 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Flex Pharma (FLKS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c